Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Graft Versus Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Early research (Phase 1)WithdrawnNCT05443464
What this trial is testing

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Who this might be right for
GVHD,Acute
Ossium Health, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01898377
What this trial is testing

Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children

Who this might be right for
Chronic Graft-versus-host Disease
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)UnknownNCT02385019
What this trial is testing

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Graft vs Host Disease
Instituto de Medicina Molecular João Lobo Antunes 22
Very early researchLooking for participantsNCT04744116
What this trial is testing

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmSteroid Refractory Graft Versus Host Disease
M.D. Anderson Cancer Center 24
Large-scale testing (Phase 3)Study completedNCT02959944
What this trial is testing

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Pharmacyclics LLC. 193
Testing effectiveness (Phase 2)UnknownNCT05095649
What this trial is testing

Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib

Who this might be right for
Chronic Graft vs Host Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 15
Large-scale testing (Phase 3)Ended earlyNCT04128319
What this trial is testing

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 3
Testing effectiveness (Phase 2)Study completedNCT00003894
What this trial is testing

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Testing effectiveness (Phase 2)WithdrawnNCT02694770
What this trial is testing

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

Who this might be right for
Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
AbGenomics B.V Taiwan Branch
Early research (Phase 1)Ended earlyNCT02436460
What this trial is testing

AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
AbGenomics B.V Taiwan Branch 4
Large-scale testing (Phase 3)Ended earlyNCT04934670
What this trial is testing

Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 12
Early research (Phase 1)Study completedNCT00529035
What this trial is testing

Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 29
Not applicableEnded earlyNCT02203578
What this trial is testing

Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Rutgers, The State University of New Jersey 1
Early research (Phase 1)Ended earlyNCT02086513
What this trial is testing

Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Massachusetts General Hospital 17
Testing effectiveness (Phase 2)UnknownNCT00472225
What this trial is testing

Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Steroid-Refractory Chronic GVHD
The Korean Society of Hematopoietic Stem Cell Transplantation 42
Early research (Phase 1)Study completedNCT01155817
What this trial is testing

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Who this might be right for
Bone Marrow Transplant FailureLymphoma, Non-HodgkinLymphoma, T-Cell, Peripheral
Stanford University 33
Testing effectiveness (Phase 2)Study completedNCT00136396
What this trial is testing

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Dana-Farber Cancer Institute 30
Next Page